How Your Menstrual Cycle May Affect Blood Sugar Control
A large review of research shows that blood sugar tends to be harder to manage during the luteal phase of the menstrual cycle, though individual responses vary widely.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- The luteal phase (roughly the second half of the menstrual cycle) is associated with higher blood sugar levels and more time spent above target range
- Time in hypoglycemia (low blood sugar) and blood sugar variability don't appear to change significantly between cycle phases
- Insulin needs don't consistently increase during the luteal phase across all people—responses are highly individualized
- Tracking your own patterns with CGM data may help you recognize if and how your cycle affects your diabetes management
What the Research Found
Researchers reviewed 18 studies examining how the menstrual cycle affects blood sugar control in adolescent girls and women with type 1 diabetes. The analysis focused on comparing two main phases: the follicular phase (roughly the first half of the cycle) and the luteal phase (roughly the second half).
The findings show a consistent pattern: during the luteal phase, people experienced lower time in range, more time with blood sugar above target, and higher average glucose readings on continuous glucose monitors. However, low blood sugar episodes and glucose variability stayed roughly the same across both phases.
Insulin Adjustments Vary From Person to Person
One might expect that if blood sugar rises during the luteal phase, people would need significantly more insulin. The research tells a more nuanced story. Total daily insulin and bolus (mealtime) insulin amounts didn't show major differences between cycle phases overall.
This suggests that while the luteal phase does affect blood sugar, the way people's bodies compensate with insulin is highly individual. Some people may need more insulin, while others may not adjust their intake at all. The patterns also differed depending on whether people used automated insulin delivery systems or conventional insulin therapy.
What This Means for You
If you menstruate and live with type 1 diabetes, this research validates what many people have suspected: your cycle may play a role in your blood sugar patterns. However, because responses are so individualized, there's no one-size-fits-all approach.
Tracking your CGM data alongside your cycle over a few months may help you identify your own patterns. Some people notice clear changes; others don't. Understanding your personal response can help inform conversations with your care team about potential adjustments to your diabetes management plan.
Evidence label
Source: Diabetes research and clinical practice. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Our own writing on the same ground.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryLiving With T1DWhat We're Learning About Diabetic Ketoacidosis in Type 1 Diabetes: A French StudyPubMed indexed literature
- Research summaryLiving With T1DCorrection to "The Use of an Automated Insulin Delivery System Is Associated With a Reduction in Diabetes Distress and Improvement in Quality of Life in People With Type 1 Diabetes".PubMed indexed literature
- Research summaryLiving With T1DA New Class of Biologics Could Change How We Treat Type 1 DiabetesPubMed indexed literature
- Research summaryLiving With T1DMenopause and Type 1 Diabetes: What Women Need to KnowPubMed indexed literature
- Research summaryLiving With T1DThe Promise and Challenge of Oral Insulin: Where the Research StandsPubMed indexed literature
- Research summaryLiving With T1DYour Glucose Range May Not Be the Guideline Range—And That's Worth UnderstandingPubMed indexed literature